Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein

Antiviral drug resistance for influenza therapies remains a concern due to the high prevalence of H1N1 2009 seasonal influenza isolates which display H274Y associated oseltamivir-resistance. Furthermore, the emergence of novel H1N1 raises the potential that additional reassortments can occur, result...

Descripción completa

Detalles Bibliográficos
Autores principales: Triana-Baltzer, Gallen B., Gubareva, Larisa V., Klimov, Alexander I., Wurtman, David F., Moss, Ronald B., Hedlund, Maria, Larson, Jeffrey L., Belshe, Robert B., Fang, Fang
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770896/
https://www.ncbi.nlm.nih.gov/pubmed/19893749
http://dx.doi.org/10.1371/journal.pone.0007838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770896/
https://www.ncbi.nlm.nih.gov/pubmed/19893749
http://dx.doi.org/10.1371/journal.pone.0007838

Ejemplares similares